{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:12:52Z","timestamp":1786975972938,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd004362","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T00:00:00Z","timestamp":1153267200000}}],"reference-count":60,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004362.pub2","type":"journal-article","created":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T16:38:24Z","timestamp":1153240704000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Haloperidol alone or in combination for acute mania"],"prefix":"10.1002","volume":"2010","author":[{"given":"Andrea","family":"Cipriani","sequence":"first","affiliation":[{"name":"University of Verona; Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology; Policlinico \"G.B.Rossi\" Piazzale L.A. Scuro, 10 Verona Italy 37134"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M","family":"Rendell","sequence":"additional","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Hospital Oxford UK OX3 7JX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Geddes","sequence":"additional","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Hospital Oxford UK OX3 7JX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"key":"10.1002\/14651858.CD004362.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0447.1993.tb03329.x","article-title":"A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis","volume":"87","author":"Baastrup","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/08039489009096565","article-title":"Zuclopenthixol acetate, haloperidol, and zuclopenthixol in the treatment of acutely psychotic patients: A controlled multicenter study","volume":"44","author":"Fensbo","year":"1990","journal-title":"Nordisk Psykiatrisk Tidsskrift"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0003|cit3","doi-asserted-by":"crossref","unstructured":"Brecher M Huizar K Quetiapine monotherapy for acute mania associated with bipolar disorder Fifth International Conference on Bipolar Disorder, Pittsburgh, Pennsylvania 2003","DOI":"10.1016\/S0924-977X(03)92086-4"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00004850-198907000-00005","article-title":"Carbamazepine compared to haloperidol in acute mania","volume":"4","author":"Brown","year":"1989","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0165-0327(80)90029-4","article-title":"A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania","volume":"2","author":"Garfinkel","year":"1980","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004362.pub2-BIB0006|cit6","first-page":"15","article-title":"Comparison of therapeutic effect on mania of sultopride hydrochloride with haloperidol using double-blind technique","volume":"15","author":"Kudo","year":"1987","journal-title":"Rinsho Hyoka"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0007|cit7","first-page":"47","article-title":"Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study","volume":"53","author":"Lenox","year":"1992","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0008|cit8","first-page":"142","article-title":"A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania","volume":"57","author":"McElroy","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004362.pub2-BIB0009|cit9","first-page":"44","article-title":"Carbamazepine vs haloperidol in treatment of manic episodes: A controlled clinical trial","volume":"16","author":"Ortega Soto","year":"1993","journal-title":"Salud Mental"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0011|cit11","unstructured":"Sanchez R Bourin M Auby P Swanik R Marcus R McQuade RD Fifth International Conference on Bipolar Disorder"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0012|cit12","first-page":"176","article-title":"Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial","volume":"21","author":"Segal","year":"1998","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archpsyc.1975.01760190036004","article-title":"Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol","volume":"32","author":"Shopsin","year":"1975","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0014|cit14","first-page":"265","article-title":"Lithium combined with carbamazepine or haloperidol in the treatment of mania","volume":"31","author":"Small","year":"1995","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD004362.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2004.06.003","article-title":"Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol","volume":"15","author":"Smulevich","year":"2005","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00004850-200209000-00003","article-title":"Olanzapine versus haloperidol in the treatment of acute mania: Clinical outcomes, health-related quality of life and work status","volume":"17","author":"Shi","year":"2002","journal-title":"International Clinical Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD004362.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archpsyc.60.12.1218","article-title":"A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania","volume":"60","author":"Tohen","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0018|cit18","unstructured":"Tohen M Zhang F Feldman P Olanzapine versus haloperidol in the treatment of acute mania British Association of Psychopharmacologicum, Harrogate, UK 2002"},{"issue":"1","key":"10.1002\/14651858.CD004362.pub2-BIB0019|cit19","first-page":"44","article-title":"Zuclopenthixol versus haloperidol in the initial treatment of schizophrenic psychoses, affective psychoses and paranoid states: A controlled clinical trial","volume":"7","author":"Al Haddad","year":"1996","journal-title":"Arab Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004362.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-0327(99)00134-2","article-title":"Pretreatment plasma HVA and haloperidol response in acute mania","volume":"59","author":"Chou","year":"2000","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1002\/14651858.CD004362.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00004714-200108000-00013","article-title":"Haloperidol blood levels in acute mania with psychosis","volume":"21","author":"Chou","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0022|cit22","first-page":"29","article-title":"Clonazepam in acute and maintenance treatment of bipolar affective disorder","volume":"48 Suppl","author":"Chouinard","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0023|cit23","first-page":"114","article-title":"A double-blind randomized clinical trial of rapid tranquilization with IM clonazepam and IM haloperidol in agitated psychotic patients with manic symptoms","volume":"38 Suppl 4","author":"Chouinard","year":"1993","journal-title":"Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00004714-200108000-00002","article-title":"A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder","volume":"21","author":"Janicak","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004362.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0278-5846(84)90138-6","article-title":"Rapid tranquilization: a comparative study of thiothixene and haloperidol","volume":"8","author":"Kelwala","year":"1984","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD004362.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1176\/ajp.136.8.1061","article-title":"Acute high-dose parenteral haloperidol treatment of psychosis","volume":"136","author":"Lerner","year":"1979","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0033-3182(73)71377-3","article-title":"Rapid tranquilization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine","volume":"14","author":"Man","year":"1973","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0028|cit28","first-page":"617","article-title":"Flupentixol versus haloperidol in acute psychotic incident","volume":"82","author":"Parent","year":"1982","journal-title":"Acta Psychiatrica Belgica"},{"issue":"2","key":"10.1002\/14651858.CD004362.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00004714-200204000-00004","article-title":"The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine","volume":"22","author":"Potkin","year":"2002","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004362.pub2-BIB0030|cit30","first-page":"144","article-title":"Dose and blood levels of haloperidol in treatment of mania","volume":"26","author":"Rifkin","year":"1990","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1192\/bjp.165.1.113","article-title":"Dosage of haloperidol for mania.","volume":"165","author":"Rifkin","year":"1994","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0032|cit32","first-page":"92","article-title":"Sultopride versus haloperidol for the treatment of acute psychosis. Results of a multicenter double-blind controlled trial","volume":"4","author":"Ropert","year":"1989","journal-title":"Annales de Psychiatrie"},{"issue":"2","key":"10.1002\/14651858.CD004362.pub2-BIB0033|cit33","first-page":"63","article-title":"Symptomatic predictors of ECT response in medication-nonresponsive manic patients","volume":"53","author":"Schnur","year":"1992","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-0327(00)00303-7","article-title":"Olanzapine versus haloperidol in schizoaffective disorder, bipolar type","volume":"67","author":"Tohen","year":"2001","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0035|cit35","doi-asserted-by":"crossref","unstructured":"Gaszner P Pharmacological treatment of mania (the use of code-HD) XXth Collegium Internationale Neuro psychopharmacologicum, Melbourne, Australia 1996","DOI":"10.1016\/0924-977X(96)87336-6"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0036|cit36","doi-asserted-by":"crossref","unstructured":"Malykhin N Comparative efficacy of risperidone, clozapine and haloperidol in the treatment of schizoaffective disorders with manic symptoms European Neuropsychopharmacology 2003 S304","DOI":"10.1016\/S0924-977X(03)92012-8"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1034\/j.1399-5618.2002.01184.x","article-title":"Are patients with bipolar affective disorder socially disadvantaged? A comparison with a control group","volume":"4","author":"Abood","year":"2002","journal-title":"Bipolar Disorders"},{"issue":"6","key":"10.1002\/14651858.CD004362.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0006-3223(00)00909-4","article-title":"Historical perspectives and natural history of bipolar disorder","volume":"48","author":"Angst","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0039|cit39","volume-title":"Diagnostic and statistical manual of mental disorders. DSM-IV","author":"American Psychiatric Association","year":"1994"},{"issue":"4","key":"10.1002\/14651858.CD004362.pub2-BIB0040|cit40","article-title":"Lithium for maintenance treatment of mood disorders (Cochrane Review)","author":"Burgess","year":"2002","journal-title":"The Cochrane Library"},{"issue":"3","key":"10.1002\/14651858.CD004362.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/schbul\/16.3.477","article-title":"Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients","volume":"16","author":"Cassens","year":"1990","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/gps.504","article-title":"A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients","volume":"16","author":"Chan","year":"2001","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","article-title":"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis","volume":"321","author":"Geddes","year":"2000","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0044|cit44","volume-title":"Manic-depressive illness","author":"Goodwin","year":"1990"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1192\/bjp.170.3.205","article-title":"Suicide as an outcome for mental disorders: a meta-analysis","volume":"170","author":"Harris","year":"1997","journal-title":"British Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD004362.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1176\/ajp.151.10.1409","article-title":"One hundred years of schizophrenia: a meta-analysis of the outcome literature","volume":"151","author":"Hegarty","year":"1994","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD004362.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1176\/ajp.149.7.898","article-title":"Neuropsychological functioning of first-episode schizophreniform patients","volume":"149","author":"Hoff","year":"1992","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004362.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF02244982","article-title":"Pharmacologic treatment of schizoaffective disorder","volume":"114","author":"Keck","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0920-9964(98)00165-0","article-title":"Schizoaffective disorder: role of atypical antipsychotics","volume":"35 Suppl","author":"Keck","year":"1999","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1017\/S0033291797005333","article-title":"The epidemiology of DSM-III-R bipolar I disorder in a general population survey","volume":"27","author":"Kessler","year":"1997","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0006-3223(00)00961-6","article-title":"Pharmacologic agents for the treatment of acute bipolar mania","volume":"48","author":"McElroy","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0052|cit52","first-page":"S15","article-title":"Psychotropic drugs and adverse events in the treatment of Bipolar Disorders revisited","volume":"63 Suppl 3","author":"McIntyre","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","article-title":"Global mortality, disability and contribution of risk factors: Global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD004362.pub2-BIB0054|cit54","first-page":"516","article-title":"A multicentre study on the efficacy and safety of individualized dosage of haloperidol (Haldol) in refractory chronic psychotics","volume":"77","author":"Nicodeme","year":"1977","journal-title":"Acta Psychiatrica Belgica"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0055|cit55","first-page":"131","article-title":"Genetics","volume-title":"Handbook of Affective Disorders","author":"Nurnberger","year":"1992"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0056|cit56","volume-title":"The Cochrane Collaboration Handbook","author":"Sackett","year":"1997"},{"issue":"1","key":"10.1002\/14651858.CD004362.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/ajp.156.1.79","article-title":"Olanzapine versus haloperidol treatment in first-episode psychosis","volume":"156","author":"Sanger","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1176\/ps.50.10.1303","article-title":"Health care utilization and costs among patients treated for bipolar disorder in an insured population","volume":"50","author":"Simon","year":"1999","journal-title":"Psychiatric Services"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1055\/s-2002-33055","article-title":"Differences between unipolar and bipolar affective disorders","volume":"70","author":"Spie\u00dfl","year":"2002","journal-title":"Fortschritte der Neurologie \u00b7 Psychiatrie"},{"key":"10.1002\/14651858.CD004362.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1192\/bjp.174.1.15","article-title":"Olanzapine versus haloperidol in the treatment of schizoaffective disorder. Acute and long-term therapy","volume":"174","author":"Tran","year":"1999","journal-title":"British Journal of Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004362.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:18:36Z","timestamp":1776662316000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004362.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,7,19]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004362.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,19]]}}}